Kinstellar has advised its client TEVA, the world’s largest generic drug company by sales, on the Hungarian and Bulgarian aspects of its $40.5bn global acquisition of Allergan Group. The deal combines two leading generics businesses with complementary strengths, particularly with respect to product pipelines and portfolios in these respective markets.
The Kinstellar team was: Partner Anthony O’Connor, Counsel Ákos Nagy, Associates Eszter Takácsi-Nagy, Ferenc Dávid, Junior Associates Áron Barta, Evelin Szőke and Barnabás Sági in Budapest; Partner Diana Dimova, Counsel Dessislava Fessenko, Managing Associates Nina Tsifudina and Svilen Issaev, Associates Plamena Deliyska, Vanya Shubelieva, Vladimir Sotirov, Mileslava Bogdanova and Stiliyana Ivanova in Sofia.
